Dosage and administration
adults&children 6 years &older(with adult supervision ) 2 or 3 sprays in each nostril, not more often than every 10 to 12 hours.Do not exceed 2 doses in 24 hours
adults&children 6 years &older(with adult supervision ) 2 or 3 sprays in each nostril, not more often than every 10 to 12 hours.Do not exceed 2 doses in 24 hours
do not exceed 25°C.
Naphazoline HCL 0.05%.
Nasal Decongestant
temporarily relieves
·nasal congestion due to a cold, hay fever, or other upper respiratory allergies
·sinus congestion and pressure
Ask a doctor before use if you have
·heart disease
·high blood pressure
·thyroid disease
·diabetes
·trouble urinating due to enlarged prostate gland
·do not exceed recommended dosage
·do not use this product for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen
·temporary discomfort such as burning, stinging,sneezing, or increased nasaldischarge may occur
·use of this container by more than one person may spread infection
do not use children under 2 years.
·do not exceed recommended dosage
·do not use this product for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen
·temporary discomfort such as burning, stinging,sneezing, or increased nasaldischarge may occur
·use of this container by more than one person may spread infection
Stop use and ask a doctor if symptoms persist.
If pregnant or breast-feeding, ask a health professional before use.
children 2 to under 6 years.
If swallowed,get medical help or contact a Poison Control Center right away
adults&children 6 years &older(with adult supervision ) 2 or 3 sprays in each nostril, not more often than every 10 to 12 hours.Do not exceed 2 doses in 24 hours
do not exceed 25°C.
borneol,Camphor,glycerin,menthol,propylene glycol,etc.
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84010-117 | 84010-117-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | IACT |
| NAPHAZOLINE HCL | MZ1131787D | ACTIB |
| BORNEOL | M89NIB437X | IACT |
| CAMPHOR (SYNTHETIC) | 5TJD82A1ET | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4a4bb9a1-24a0-1025-e063-6294a90a52b8 | 35c90ed6-8b07-9507-e063-6394a90a6799 | 2026-02-08 | Warnings | 35c90ed6-8b07-9507-e063-6394a90a6799 |
Adverse event summaries are temporarily unavailable. Other product information remains available.